BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Concert Pharmaceuticals, Inc. 

99 Hayden Avenue
Suite 500
Lexington  Massachusetts  02421  U.S.A.
Phone: 781-860-0045 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical

Segment
Start Up





 Company News
Concert Pharmaceuticals, Inc. (CNCE) To Be Added To NASDAQ Biotechnology Index 12/15/2014 10:26:41 AM
Concert Pharmaceuticals, Inc. (CNCE) Names Thomas Auchincloss To Board Of Directors And Chair Of The Audit Committee 12/10/2014 8:46:11 AM
Jazz Pharmaceuticals (JAZZ) And Concert Pharmaceuticals, Inc. (CNCE) Provide JZP-386 Program Update 12/9/2014 11:16:49 AM
Concert Pharmaceuticals, Inc. (CNCE) Reports Third Quarter 2014 Financial Results And Provides Update On CTP-354 Program 11/12/2014 9:54:54 AM
Concert Pharmaceuticals, Inc. (CNCE) To Present At Stifel 2014 Healthcare Conference On November 18, 2014 11/11/2014 9:47:37 AM
Concert Pharmaceuticals, Inc. (CNCE) To Present At Stifel 2014 Healthcare Conference On November 18, 2014 11/11/2014 9:22:31 AM
Concert Pharmaceuticals, Inc. (CNCE) To Report Third Quarter 2014 Results On November 12, 2014 11/5/2014 10:04:32 AM
Concert Pharmaceuticals, Inc. (CNCE) Presents Positive Data From Multiple Dose Phase 1 Clinical Trial Of CTP-354, Lead Candidate For The Treatment Of Spasticity 10/13/2014 11:13:32 AM
Concert Pharmaceuticals, Inc. (CNCE) Announces Initiation Of CTP-730 Phase 1 Clinical Trial Under Celgene (CELG) Collaboration 9/17/2014 9:25:54 AM
Concert Pharmaceuticals, Inc. (CNCE) Achieves $2 Million Milestone For AVP-786 Under AVANIR Pharmaceuticals (AVNR) Collaboration 8/26/2014 9:28:38 AM
12345678910...